SE418294B - Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester - Google Patents

Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester

Info

Publication number
SE418294B
SE418294B SE7503356A SE7503356A SE418294B SE 418294 B SE418294 B SE 418294B SE 7503356 A SE7503356 A SE 7503356A SE 7503356 A SE7503356 A SE 7503356A SE 418294 B SE418294 B SE 418294B
Authority
SE
Sweden
Prior art keywords
9alfa
16alfa
fluorosteroid
16beta
chlorine
Prior art date
Application number
SE7503356A
Other languages
English (en)
Swedish (sv)
Other versions
SE7503356L (cs
Inventor
J E Villax
Original Assignee
Plurichemie Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plurichemie Anstalt filed Critical Plurichemie Anstalt
Publication of SE7503356L publication Critical patent/SE7503356L/
Publication of SE418294B publication Critical patent/SE418294B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7503356A 1974-03-27 1975-03-24 Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester SE418294B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT6163774 1974-03-27
PT6163674 1974-03-27

Publications (2)

Publication Number Publication Date
SE7503356L SE7503356L (cs) 1975-09-29
SE418294B true SE418294B (sv) 1981-05-18

Family

ID=26653426

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7503356A SE418294B (sv) 1974-03-27 1975-03-24 Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester

Country Status (9)

Country Link
US (1) US4024131A (cs)
JP (2) JPS6043358B2 (cs)
AU (1) AU500060B2 (cs)
CA (1) CA1065848A (cs)
DE (1) DE2512915A1 (cs)
HK (2) HK64679A (cs)
NL (1) NL184321C (cs)
PH (1) PH13537A (cs)
SE (1) SE418294B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201778A (en) * 1977-11-08 1980-05-06 Schering Corporation 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
EP0029151B1 (en) * 1979-11-16 1985-09-25 STEROSYNT Ltd. 6-alpha-fluoro-9-alpha-chloro-prednisolone-17,21 diesters, pharmaceutical compositions containing them and intermediates
PT71309A (en) * 1980-05-27 1980-06-01 Hovione Sociedade Quimica Lda Process of selective
IL66432A0 (en) * 1981-08-04 1982-12-31 Plurichemie Anstalt Process for the preparation of steroidal esters
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
JPS62111184U (cs) * 1985-12-29 1987-07-15
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
CN101518537A (zh) * 2000-12-22 2009-09-02 日本新药株式会社 炎症性呼吸道疾病的预防/治疗剂
CN104558082B (zh) * 2013-10-16 2018-01-23 天津金耀集团有限公司 一种倍氯米松双丙酸酯的合成方法
CN104558083B (zh) * 2013-10-16 2018-08-31 天津金耀集团有限公司 一种倍氯米松双丙酸酯无有机溶剂的合成方法
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB1070751A (en) * 1964-01-28 1967-06-01 Glaxo Lab Ltd 17-esters of 17-hydroxy-21-desoxy-steroids
NL6612191A (cs) * 1965-08-30 1967-03-01
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
CH513845A (de) * 1967-11-17 1971-10-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Halogenpregnadiene
GB1227992A (cs) * 1968-01-23 1971-04-15 Koninklijke Gist Spiritus
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
BE785812A (fr) * 1971-07-05 1973-01-04 Glaxo Lab Ltd Nouveaux composes steroides

Also Published As

Publication number Publication date
CA1065848A (en) 1979-11-06
AU500060B2 (en) 1979-05-10
NL7503788A (nl) 1975-09-30
JPS50157353A (cs) 1975-12-19
DE2512915A1 (de) 1975-10-09
NL184321C (nl) 1989-06-16
PH13537A (en) 1980-06-19
JPS6241680B2 (cs) 1987-09-03
HK64779A (en) 1979-09-21
NL184321B (nl) 1989-01-16
US4024131A (en) 1977-05-17
DE2512915C2 (cs) 1987-09-10
SE7503356L (cs) 1975-09-29
AU7960375A (en) 1976-09-30
JPS58189200A (ja) 1983-11-04
HK64679A (en) 1979-09-21
JPS6043358B2 (ja) 1985-09-27

Similar Documents

Publication Publication Date Title
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE420405B (sv) Sett att framstella ett polykarboxylatcement
SE383910B (sv) Sett att tillverka betongkonstruktioner
SE7412207L (sv) Sett att frilegga cellulosafibrer
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE7505009L (sv) Sett att framstella vetgas.
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE415714B (sv) Sett att framstella en koaxialkabel
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE7506392L (sv) Sett att framstella plaster
SE418294B (sv) Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE407944B (sv) Sett att framstella koks
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE427930B (sv) Sett att atervinna organotennhalogenider
SE414179B (sv) Sett att framstella alkylfosfiner
SE7512472L (sv) Sett att framstella cefalosporiner
SE7508683L (sv) Sett att framstella glycidyletrar
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE428471B (sv) Sett att framstella imidazolderivat
SE7513234L (sv) Sett att framstella en vanadinkatalysator
SE413958B (sv) Sett att framstella en tyristor
SE404529B (sv) Sett att framstella en diester av 17beta-hydroxi-deltaŸ4-ostren-3-on

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7503356-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7503356-3

Format of ref document f/p: F